MATINAS BIOPHARMA HOLDINGS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $6.10 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-11-10
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $6.10M.
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $89.58K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.10M derived: sum of 2 quarters · filed 2025-11-10 | $6.10M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $6.10M 10-Q · filed 2025-08-14 | $6.10M 10-Q · filed 2025-08-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-09 | $89.58K derived: sum of 3 quarters · filed 2020-03-09 | $89.58K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $89.58K derived: sum of 2 quarters · filed 2019-11-13 | $89.58K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $89.58K 10-Q · filed 2019-08-13 | $89.58K 10-Q · filed 2019-08-13 | $16.70M 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $16.70M 10-Q · filed 2018-05-09 | ||||
| 2013-12-31 | $138.32K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |